Intellia Therapeutics to Present at November Healthcare Investor Conferences

World News: . []

CAMBRIDGE Mass Nov 08 2018 GLOBE NEWSWIRE -- Intellia Therapeutics Inc NASDAQNTLA a leading genome editing company focused on developing curative therapeutics using CRISPRCas9 technology both and will participate in the following upcomin...

More news and information about Intellia Therapeutics, Inc.

Published By:

Globe Newswire: 21:30 GMT Thursday 8th November 2018

Published: .

Search for other references to "intellia" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us